The CEASE-AF randomized-controlled trial highlights the long-term effectiveness of Hybrid ablation, showing sustained results over 24 months and a ~33% absolute increase in freedom from atrial arrhythmias* for patients with LSPAF.
Discover more: <a href="https://t.co/Zs4xjdLb6U" target="_blank">https://t.co/Zs4xjdLb6U</a>… <a href="https://t.co/nKLoTxSLw0" target="_blank">https://t.co/nKLoTxSLw0</a>